Nationwide
Phase 2 Trial of Adoptive Cell Therapy with TILs Plus IL-2
National Cancer Institute (NCI)
Ph 2·~14yr·1 site in MD
National Cancer Institute (NCI)
University of Louisville
Krystal Biotech, Inc.
Memorial Sloan Kettering Cancer Center
Daiichi Sankyo
Iovance Biotherapeutics, Inc.
Ipsen
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc.
Nested Therapeutics, Inc
H. Lee Moffitt Cancer Center and Research Institute
St. Jude Children's Research Hospital
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center